RxDoctor Payments DataLook up a doctor →

Gary Gregerson, MD

Obstetrics & Gynecology · Nampa, IDNPI 1801834866

Payments from drug & device makers

$1,918,702in general payments, 2019–2025

Across 568 payments — averaging $3378.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$731K
  • GSK$543K
  • Pfizer$483K
  • Evofem Biosciences, Inc.$150K
  • Astellas Pharma US Inc$5K
  • Sun Pharmaceutical Industries Inc.$5K
  • plus $404 from 15 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,918,702 in reported general payments places this provider in the 95th percentile of 166 obstetrics & gynecology providers in Idaho.

See all obstetrics & gynecology providers in Idaho

Medicare billing

Part B allowed, 2024
$26,518
Medicare patients
81
Services billed
290

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other obstetrics & gynecology in Nampa

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →